Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety, efficacy, and pharmacokinetics of GreenGene F in previously treated patients with severe Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• GreenGene F

Snippet

Sponsor: Green Cross Corporation | Conditions: Hemophilia A | Phase 3 | Status: UNKNOWN